Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP690072.RAZ9G9xmb3DAAGInQz5wDcseyEKT-cbbPJ6Q0HbhcO0lk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP690072.RAZ9G9xmb3DAAGInQz5wDcseyEKT-cbbPJ6Q0HbhcO0lk130_assertion type Assertion NP690072.RAZ9G9xmb3DAAGInQz5wDcseyEKT-cbbPJ6Q0HbhcO0lk130_head.
- NP690072.RAZ9G9xmb3DAAGInQz5wDcseyEKT-cbbPJ6Q0HbhcO0lk130_assertion description "[We conducted a double-blind, placebo-controlled trial of 4 weeks of intranasal fluticasone propionate or matching placebo to assess their effectiveness in reducing NP inflammatory cells, expression of endothelial vascular cell adhesion molecule (VCAM)-1 and P-selectin, and expression of cytokines involved in induction of a group of adhesion molecules (ie, IL-4, IL-13, TNF-alpha, and IL-1beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690072.RAZ9G9xmb3DAAGInQz5wDcseyEKT-cbbPJ6Q0HbhcO0lk130_provenance.
- NP690072.RAZ9G9xmb3DAAGInQz5wDcseyEKT-cbbPJ6Q0HbhcO0lk130_assertion evidence source_evidence_literature NP690072.RAZ9G9xmb3DAAGInQz5wDcseyEKT-cbbPJ6Q0HbhcO0lk130_provenance.
- NP690072.RAZ9G9xmb3DAAGInQz5wDcseyEKT-cbbPJ6Q0HbhcO0lk130_assertion SIO_000772 9893189 NP690072.RAZ9G9xmb3DAAGInQz5wDcseyEKT-cbbPJ6Q0HbhcO0lk130_provenance.
- NP690072.RAZ9G9xmb3DAAGInQz5wDcseyEKT-cbbPJ6Q0HbhcO0lk130_assertion wasDerivedFrom befree-20150227 NP690072.RAZ9G9xmb3DAAGInQz5wDcseyEKT-cbbPJ6Q0HbhcO0lk130_provenance.
- NP690072.RAZ9G9xmb3DAAGInQz5wDcseyEKT-cbbPJ6Q0HbhcO0lk130_assertion wasGeneratedBy ECO_0000203 NP690072.RAZ9G9xmb3DAAGInQz5wDcseyEKT-cbbPJ6Q0HbhcO0lk130_provenance.